| Financial Year |
March 31 2023 |
| Monetary Funds |
1,077,188,040.27 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
24,893,947.27 |
| Advances to Suppliers |
135,598,085.72 |
| Other Receivables |
49,524,823.57 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
265,003,796.94 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
23,638,661.88 |
| Total Current Assets |
1,746,760,482.10 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
1,055,034,152.44 |
| Under-construction Projects |
1,160,309,246.79 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,817,891,595.41 |
| R&D expenses |
3,303,898.31 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
75,752,084.24 |
| Deferred Income Tax Assets |
70,987,487.19 |
| Other Non-Current Assets |
18,951,085.94 |
| Sub-Total of Non-Current Assets |
4,207,799,595.26 |
| Total Assets |
5,954,560,077.36 |
| Short-Term Loans |
1,455,023,492.90 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
296,547,660.02 |
| Accounts Received In Advance |
723,248.91 |
| Employee Compensation Payable |
71,616,863.11 |
| Taxes Payable |
54,140,301.21 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
95,596,368.43 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,213,011,721.80 |
| Other Current Liabilities |
5,645,833.84 |
| Sub-Total of Current Liabilities |
3,235,876,411.04 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
36,320,213.17 |
| Deferred Income Tax Liabilities |
153,250,513.39 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
210,410,389.08 |
| Total Liabilities |
3,446,286,800.12 |
| Paid-In Capital(Or Share Stock) |
592,379,938.00 |
| Capital Surplus |
1,474,613,690.87 |
| Surplus Reserve |
57,005,751.71 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-117,947,505.44 |
| Minority Stockholder's Interest |
498,834,435.44 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,009,438,841.80 |
| Owner's Equity（Stockholder's Equity） |
2,508,273,277.24 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,954,560,077.36 |
